MiMedx Group, Inc. (MDXG)
USD 6.89
(-2.41%)
USD 6.89
(-2.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 266.84 Million USD | 21.55% |
| 2022 | 219.52 Million USD | 1.95% |
| 2021 | 215.33 Million USD | 3.08% |
| 2020 | 208.9 Million USD | -18.45% |
| 2019 | 256.17 Million USD | -20.62% |
| 2018 | 322.72 Million USD | 12.87% |
| 2017 | 285.92 Million USD | 34.48% |
| 2016 | 212.6 Million USD | 27.24% |
| 2015 | 167.09 Million USD | 58.3% |
| 2014 | 105.55 Million USD | 111.74% |
| 2013 | 49.85 Million USD | 128.0% |
| 2012 | 21.86 Million USD | 374.73% |
| 2011 | 4.6 Million USD | 594.62% |
| 2010 | -931.18 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 71.53 Million USD | -2.0% |
| 2024 Q2 | 72.16 Million USD | 0.88% |
| 2024 Q3 | 68.73 Million USD | -4.75% |
| 2023 Q1 | 59.25 Million USD | -1.25% |
| 2023 FY | 266.84 Million USD | 21.55% |
| 2023 Q2 | 67.67 Million USD | 14.2% |
| 2023 Q3 | 66.92 Million USD | -1.11% |
| 2023 Q4 | 72.99 Million USD | 9.07% |
| 2022 FY | 219.52 Million USD | 1.95% |
| 2022 Q4 | 60 Million USD | 8.12% |
| 2022 Q1 | 48.95 Million USD | -13.59% |
| 2022 Q2 | 55.06 Million USD | 12.46% |
| 2022 Q3 | 55.5 Million USD | 0.8% |
| 2021 Q4 | 56.65 Million USD | 7.01% |
| 2021 FY | 215.33 Million USD | 3.08% |
| 2021 Q3 | 52.94 Million USD | -4.44% |
| 2021 Q2 | 55.4 Million USD | 10.09% |
| 2021 Q1 | 50.32 Million USD | -12.83% |
| 2020 Q3 | 54.01 Million USD | 18.85% |
| 2020 Q2 | 45.44 Million USD | -12.11% |
| 2020 Q4 | 57.73 Million USD | 6.88% |
| 2020 FY | 208.9 Million USD | -18.45% |
| 2020 Q1 | 51.71 Million USD | -18.81% |
| 2019 Q3 | 75.65 Million USD | 31.15% |
| 2019 FY | 256.17 Million USD | -20.62% |
| 2019 Q1 | 59.13 Million USD | -28.04% |
| 2019 Q2 | 57.68 Million USD | -2.45% |
| 2019 Q4 | 63.69 Million USD | -15.82% |
| 2018 Q4 | 82.18 Million USD | 3.24% |
| 2018 Q1 | 74.79 Million USD | -5.69% |
| 2018 FY | 322.72 Million USD | 12.87% |
| 2018 Q3 | 79.6 Million USD | -7.6% |
| 2018 Q2 | 86.14 Million USD | 15.18% |
| 2017 Q2 | 67.78 Million USD | 6.13% |
| 2017 Q3 | 74.97 Million USD | 10.61% |
| 2017 Q4 | 79.3 Million USD | 5.77% |
| 2017 FY | 285.92 Million USD | 34.48% |
| 2017 Q1 | 63.86 Million USD | 5.03% |
| 2016 Q2 | 49.94 Million USD | 9.97% |
| 2016 Q3 | 56.43 Million USD | 12.98% |
| 2016 Q1 | 45.42 Million USD | -3.05% |
| 2016 Q4 | 60.8 Million USD | 7.75% |
| 2016 FY | 212.6 Million USD | 27.24% |
| 2015 FY | 167.09 Million USD | 58.3% |
| 2015 Q1 | 35.61 Million USD | -0.98% |
| 2015 Q2 | 40.59 Million USD | 13.96% |
| 2015 Q3 | 44.03 Million USD | 8.49% |
| 2015 Q4 | 46.85 Million USD | 6.39% |
| 2014 Q2 | 22.83 Million USD | 37.7% |
| 2014 FY | 105.55 Million USD | 111.74% |
| 2014 Q4 | 35.97 Million USD | 19.24% |
| 2014 Q3 | 30.16 Million USD | 32.13% |
| 2014 Q1 | 16.58 Million USD | 11.42% |
| 2013 Q4 | 14.88 Million USD | 6.29% |
| 2013 Q3 | 14 Million USD | 23.74% |
| 2013 Q1 | 9.65 Million USD | 9.42% |
| 2013 FY | 49.85 Million USD | 128.0% |
| 2013 Q2 | 11.31 Million USD | 17.25% |
| 2012 Q1 | 2.74 Million USD | 54.97% |
| 2012 Q4 | 8.82 Million USD | 35.1% |
| 2012 Q3 | 6.52 Million USD | 73.21% |
| 2012 FY | 21.86 Million USD | 374.73% |
| 2012 Q2 | 3.76 Million USD | 37.22% |
| 2011 Q1 | 384.61 Thousand USD | 418.03% |
| 2011 Q4 | 1.77 Million USD | 35.44% |
| 2011 Q3 | 1.3 Million USD | 14.8% |
| 2011 Q2 | 1.13 Million USD | 196.4% |
| 2011 FY | 4.6 Million USD | 594.62% |
| 2010 Q1 | -264.73 Thousand USD | 0.0% |
| 2010 FY | -931.18 Thousand USD | 0.0% |
| 2010 Q4 | -120.93 Thousand USD | 71.98% |
| 2010 Q3 | -431.67 Thousand USD | -279.16% |
| 2010 Q2 | -113.85 Thousand USD | 56.99% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | -100.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | 158.26 Thousand USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -601.757% |
| Alkermes plc | 1.37 Billion USD | 80.589% |
| Agenus Inc. | 139.61 Million USD | -91.128% |
| Aptorum Group Limited | -1.11 Million USD | 24038.806% |
| Ardelyx, Inc. | 106.66 Million USD | -150.179% |
| Dyadic International, Inc. | 922.95 Thousand USD | -28811.748% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1167.001% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 152718.635% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 2097.65% |
| Novavax, Inc. | 639.93 Million USD | 58.302% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 669.703% |
| Pyxis Oncology, Inc. | -2 Million USD | 13442.15% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 51739.103% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1301.266% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 603981.144% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 50734.345% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 371.687% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -33172.195% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 325518.293% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -97.268% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -3290.205% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 375.238% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 82.42% |
| AlloVir, Inc. | -398 Thousand USD | 67145.98% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -10.845% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -62834.67% |
| Bicycle Therapeutics plc | -129.52 Million USD | 306.025% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -222269.167% |
| ChromaDex Corporation | 50.78 Million USD | -425.488% |
| Chimerix, Inc. | 324 Thousand USD | -82258.951% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 956.153% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 443.879% |
| CRISPR Therapeutics AG | 240.95 Million USD | -10.743% |
| Precision BioSciences, Inc. | 40.47 Million USD | -559.327% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 371.837% |
| Fortress Biotech, Inc. | 57.85 Million USD | -361.243% |
| Fortress Biotech, Inc. | 57.85 Million USD | -361.243% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1509.718% |
| ImmuCell Corporation | 4.39 Million USD | -5969.74% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 351.447% |
| Immix Biopharma, Inc. | -5468.00 USD | 4880184.126% |
| Incyte Corporation | 3.44 Billion USD | 92.244% |
| Innoviva, Inc. | 261.06 Million USD | -2.213% |
| IO Biotech, Inc. | -756 Thousand USD | 35396.693% |
| Jaguar Health, Inc. | 7.72 Million USD | -3354.726% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 40287.199% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -122.828% |
| ContextLogic Inc. | 59 Million USD | -352.276% |
| MEI Pharma, Inc. | 49.32 Million USD | -440.967% |
| NextCure, Inc. | -3.68 Million USD | 7343.295% |
| Onconetix, Inc. | -1.12 Million USD | 23773.819% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1021.165% |
| Opthea Limited | 21.72 Thousand USD | -1228458.932% |
| Psyence Biomedical Ltd. | -240.00 USD | 111184683.333% |
| Vaxcyte, Inc. | -75 Million USD | 455.791% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 465583.376% |
| Precigen, Inc. | 106 Thousand USD | -251638.679% |
| Pharming Group N.V. | 220.1 Million USD | -21.235% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -51714.175% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -26346.283% |
| PureTech Health plc | -1.6 Million USD | 16746.475% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -143.088% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 247.095% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 688.732% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1313.64% |
| Acelyrin, Inc. | -115 Thousand USD | 232137.391% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2654990.061% |
| Summit Therapeutics Inc. | -2.05 Million USD | 13116.732% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 46832.574% |
| Senti Biosciences, Inc. | -2.68 Million USD | 10045.695% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -6487.09% |
| Elevation Oncology, Inc. | -39 Thousand USD | 684312.821% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 5661.546% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 6869.146% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -816.073% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -53698.992% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 485269.091% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -156.336% |
| Seer, Inc. | 7.02 Million USD | -3697.396% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -5995.089% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1138.538% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 225301.07% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 186311.541% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -43716.585% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -121.494% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 14.929% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 5336960.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -10266.861% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 526002.641% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -808.031% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 115118.534% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 54336.382% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3859.411% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 56331.337% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2565898.077% |
| Soligenix, Inc. | 97.31 Thousand USD | -274116.687% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2568.711% |
| Kura Oncology, Inc. | -849 Thousand USD | 31530.271% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 497.656% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 181625.85% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -169.432% |
| Autolus Therapeutics plc | -4.86 Million USD | 5582.7% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -544.766% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 158935.119% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -181.709% |
| GRI Bio, Inc. | 10.84 Million USD | -2361.424% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -10405.688% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 3171.751% |
| IGM Biosciences, Inc. | -211.66 Million USD | 226.072% |
| INmune Bio, Inc. | 155 Thousand USD | -172056.774% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -330.816% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 17815.236% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 41250.644% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 911635.834% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -66278.856% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 13468.888% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 85353.355% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -182.49% |
| Verastem, Inc. | -62 Thousand USD | 430491.935% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -10858.645% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 102338.697% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -8715.428% |
| Histogen Inc. | 3.76 Million USD | -6979.942% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -46212.517% |
| Surrozen, Inc. | -27.23 Million USD | 1079.96% |
| Organovo Holdings, Inc. | -5.38 Million USD | 5051.624% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 22246.853% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1140.445% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1230.755% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 13477019.192% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -4298.688% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 397595.941% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -72.389% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -182919.89% |
| Apollomics, Inc. | 127 Thousand USD | -210012.598% |
| Amarin Corporation plc | 165.54 Million USD | -61.195% |
| Mesoblast Limited | -9.81 Million USD | 2818.726% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1516.642% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 341.511% |
| Synaptogenix, Inc. | -6347.00 USD | 4204338.223% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 523321.569% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -65.366% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 84.818% |
| Better Therapeutics, Inc. | -2.72 Million USD | 9878.051% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 337.911% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 21.071% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2339186.606% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 4362.668% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 24183.303% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -3546.392% |
| Insmed Incorporated | 239.63 Million USD | -11.354% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -7357.881% |
| OmniAb, Inc. | 14.66 Million USD | -1719.343% |
| Alector, Inc. | -95.05 Million USD | 380.731% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -112.419% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 713.954% |
| Zai Lab Limited | 170.9 Million USD | -56.137% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -225.907% |
| Aura Biosciences, Inc. | -1.29 Million USD | 20705.637% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -205163.846% |
| Immunic, Inc. | -111 Thousand USD | 240499.099% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1583.127% |
| Veracyte, Inc. | 248.14 Million USD | -7.534% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.818% |
| FibroGen, Inc. | 128.9 Million USD | -107.009% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 47312688.652% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2387.183% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 92.149% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -68497.172% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 24.906% |
| TG Therapeutics, Inc. | 219.1 Million USD | -21.786% |
| Galecto, Inc. | -830 Thousand USD | 32249.759% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 19366.643% |
| Fortrea Holdings Inc. | 424 Million USD | 37.065% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 409.681% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 47162.257% |
| XBiotech Inc. | -1.74 Million USD | 15400.631% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 24183.303% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 674.214% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 453.275% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -263.531% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1488.068% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 31.41% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 637.481% |
| Vaxxinity, Inc. | -2.23 Million USD | 12044.628% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 18.334% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2456.471% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -991.338% |
| NexImmune, Inc. | -1.02 Million USD | 26134.175% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4941437.037% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3855.361% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.639% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 399404.173% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 7614.587% |
| Ainos, Inc. | -253.73 Thousand USD | 105266.849% |
| Pluri Inc. | 322 Thousand USD | -82770.497% |
| Prothena Corporation plc | -129.2 Million USD | 306.533% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -429.199% |
| Celularity Inc. | 6.75 Million USD | -3850.303% |
| Rallybio Corporation | -150 Thousand USD | 177995.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 918.361% |
| MeiraGTx Holdings plc | 287 Thousand USD | -92876.655% |
| Omeros Corporation | -69.77 Million USD | 482.412% |
| Humacyte, Inc. | -76.55 Million USD | 448.587% |
| Immunocore Holdings plc | 248.39 Million USD | -7.429% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1859.134% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -327.756% |
| Blueprint Medicines Corporation | 236.58 Million USD | -12.79% |
| CalciMedica, Inc. | -58 Thousand USD | 460174.138% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 18812.693% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -818.406% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 9482.665% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 964.549% |
| Pulmatrix, Inc. | -8.22 Million USD | 3346.265% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 22907.094% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 66977.945% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 166.912% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -9513.937% |
| Cytokinetics, Incorporated | -322.59 Million USD | 182.718% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -30852.494% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 78353.079% |
| Vor Biopharma Inc. | -3.49 Million USD | 7741.552% |
| Roivant Sciences Ltd. | 109.23 Million USD | -144.283% |
| Evogene Ltd. | 1.39 Million USD | -18973.838% |
| ProKidney Corp. | -3.16 Million USD | 8520.417% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 707.677% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3791.541% |
| CorMedix Inc. | -205.56 Thousand USD | 129911.444% |
| BioLineRx Ltd. | 1.1 Million USD | -23983.303% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 439.189% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 808715.152% |
| Atai Life Sciences N.V. | -5000.00 USD | 5336960.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 219076.85% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 278061.458% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 19311.159% |
| Sagimet Biosciences Inc. | 2 Million USD | -13242.15% |
| MediciNova, Inc. | 979.7 Thousand USD | -27137.076% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 416.468% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 282309.296% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1387.805% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -9.123% |
| Biomea Fusion, Inc. | -4.2 Million USD | 6451.892% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 69.411% |
| Mereo BioPharma Group plc | 7.42 Million USD | -3493.361% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 86178.387% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2223791.667% |
| Absci Corporation | -41.84 Million USD | 737.633% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 5336960.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 449.394% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 10942.869% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -24.848% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 28457.386% |
| Allakos Inc. | -6.14 Million USD | 4445.27% |
| Imunon, Inc. | -720 Thousand USD | 37161.27% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 486.751% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 43.928% |
| BioAtla, Inc. | -103.73 Million USD | 357.245% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2339186.606% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 150011.798% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 209.894% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 85901.608% |
| XOMA Corporation | 3.86 Million USD | -6811.241% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 480.742% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1703.724% |
| aTyr Pharma, Inc. | -2.38 Million USD | 11274.33% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -2041.597% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 920248.276% |
| Viridian Therapeutics, Inc. | -1 Million USD | 26572.52% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -2052638361.538% |
| Akari Therapeutics, Plc | -4000.00 USD | 6671175.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 58.102% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -136947.784% |
| UroGen Pharma Ltd. | 73.35 Million USD | -263.784% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1099.637% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -2298289.32% |
| Orgenesis Inc. | -5.72 Million USD | 4761.013% |
| Entera Bio Ltd. | -56 Thousand USD | 476605.357% |
| GH Research PLC | -315 Thousand USD | 84812.063% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 141286.772% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 50927.238% |
| Xencor, Inc. | -85.26 Million USD | 412.976% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 120856.006% |
| Replimune Group, Inc. | -2.65 Million USD | 10150.584% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 26751.359% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -50.043% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -136947.784% |
| Portage Biotech Inc. | -54 Thousand USD | 494253.704% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 282309.296% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 70880.637% |
| OncoCyte Corporation | 413 Thousand USD | -64510.896% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 5936540.489% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 120199649.55% |
| Purple Biotech Ltd. | -196 Thousand USD | 136244.388% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2875.502% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2627.898% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2654.754% |
| HilleVax, Inc. | -2.15 Million USD | 12476.763% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 275195.876% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1778579.072% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 40046.557% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1160286.957% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 3555086.837% |
| Savara Inc. | -44.26 Million USD | 702.872% |
| Curis, Inc. | 9.81 Million USD | -2619.835% |
| Daré Bioscience, Inc. | 2.76 Million USD | -9534.984% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 213937.068% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 15533.372% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 117136.404% |
| BeiGene, Ltd. | 2.07 Billion USD | 87.164% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 9644.082% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 166.767% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -370.722% |
| Erasca, Inc. | -3.73 Million USD | 7250.134% |
| bluebird bio, Inc. | -4.03 Million USD | 6721.414% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 945748.168% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 85.988% |
| DBV Technologies S.A. | 15.72 Million USD | -1596.611% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 945748.168% |
| Moderna, Inc. | 2.15 Billion USD | 87.617% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 29263.169% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -3233.038% |
| Molecular Templates, Inc. | 50.39 Million USD | -429.503% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 49884.142% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -99.452% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 4388.701% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 778.248% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 340.122% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 7537.096% |
| MacroGenics, Inc. | 50.52 Million USD | -428.12% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 4475.91% |
| Prime Medicine, Inc. | -147.9 Million USD | 280.415% |
| Aditxt, Inc. | -111.66 Thousand USD | 239078.148% |
| Adagene Inc. | 18.11 Million USD | -1373.335% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -54580.943% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -90.328% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -69.063% |
| SciSparc Ltd. | 2.19 Million USD | -12051.321% |
| Vericel Corporation | 135.57 Million USD | -96.822% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1065384.043% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 861383.971% |
| Generation Bio Co. | -73.91 Million USD | 461.033% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 61162.471% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -388.553% |
| Invivyd, Inc. | -2.02 Million USD | 13257.939% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 188.699% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 258073.859% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -176.9% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -171.491% |
| ADMA Biologics, Inc. | 88.21 Million USD | -202.481% |
| Clene Inc. | 533 Thousand USD | -49964.353% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -1006.811% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 27983.281% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1387.805% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -13322.686% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 137424.255% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -435.776% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3862.592% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 32019.019% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -219.898% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -364878.389% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -401.943% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 254.077% |
| Trevena, Inc. | 1.45 Million USD | -18239.725% |
| Surrozen, Inc. | -27.23 Million USD | 1079.96% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 75692.918% |
| Cingulate Inc. | -582.91 Thousand USD | 45877.108% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 860883.871% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1454.602% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 3525106.605% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 30388.649% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 60.799% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 27108.401% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 473712.935% |
| Kronos Bio, Inc. | 1.37 Million USD | -19349.198% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 597.229% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 91484.589% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 54745.781% |
| ImmunityBio, Inc. | -17.89 Million USD | 1591.576% |
| Korro Bio, Inc. | -3.63 Million USD | 7451.047% |
| Kineta, Inc. | 5.43 Million USD | -4811.522% |
| BioVie Inc. | -229.37 Thousand USD | 116433.809% |
| Codexis, Inc. | 57.33 Million USD | -365.418% |
| Celularity Inc. | 6.75 Million USD | -3850.303% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -6549.464% |
| Celcuity Inc. | -142.77 Thousand USD | 187001.493% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -527361.949% |
| Cibus, Inc. | 1.42 Million USD | -18665.331% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 71448.396% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1264.287% |
| IN8bio, Inc. | -2.5 Million USD | 10769.452% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1128.416% |
| Annexon, Inc. | -3.26 Million USD | 8267.83% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 13154.941% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 739.344% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -41594.219% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 65.724% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -54.285% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 14144.368% |
| Arcellx, Inc. | 108.27 Million USD | -146.44% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 924.378% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -236.906% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1361.55% |
| Moolec Science SA | -143.3 Thousand USD | 186306.343% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 730.566% |
| Geron Corporation | -123.5 Million USD | 316.062% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -8018.132% |
| Royalty Pharma plc | 1.79 Billion USD | 85.125% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 480.715% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 7387779.956% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -115221.253% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 339.506% |
| Humacyte, Inc. | -76.55 Million USD | 448.587% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 28213.181% |
| 89bio, Inc. | -273 Thousand USD | 97844.689% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 21328.56% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 31567.335% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 217045.528% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -23746.559% |
| Notable Labs, Ltd. | 113 Thousand USD | -236044.248% |
| Liquidia Corporation | 14.6 Million USD | -1727.692% |
| Mustang Bio, Inc. | -2.22 Million USD | 12092.944% |
| Immunovant, Inc. | -231 Thousand USD | 115616.45% |
| Quantum-Si incorporated | 488 Thousand USD | -54580.943% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 580.288% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 889576.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -14230.988% |
| Acasti Pharma Inc. | -11 Thousand USD | 2425945.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 130510.963% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 41250.644% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 259.298% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -23419.1% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 70137.533% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 13728.345% |
| PepGen Inc. | -1.18 Million USD | 22637.416% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 210212.598% |
| United Therapeutics Corporation | 2.07 Billion USD | 87.109% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1265.406% |
| Solid Biosciences Inc. | -76.56 Million USD | 448.527% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 323220.981% |
| Immuneering Corporation | -764.13 Thousand USD | 35020.787% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -402596.789% |
| Belite Bio, Inc | -399 Thousand USD | 66977.945% |
| XOMA Corporation | 3.86 Million USD | -6811.241% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1431.818% |
| Bionomics Limited | -434.44 Thousand USD | 61521.018% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 24945.717% |
| uniQure N.V. | 2.21 Million USD | -11947.088% |
| Cassava Sciences, Inc. | -89.42 Million USD | 398.405% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 389.829% |
| Forte Biosciences, Inc. | -9000.00 USD | 2965022.222% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 32057.246% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 61162.471% |
| Altimmune, Inc. | -65.37 Million USD | 508.185% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 26.293% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 24945.717% |
| Compugen Ltd. | 31.45 Million USD | -748.333% |
| Peak Bio, Inc. | 367.76 Thousand USD | -72457.23% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -988.444% |
| Benitec Biopharma Inc. | 108 Thousand USD | -246976.852% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 342206.41% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 22281.463% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 14745.609% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 224337.815% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 22281.463% |
| Instil Bio, Inc. | -4.75 Million USD | 5710.66% |
| argenx SE | 1.1 Billion USD | 75.927% |
| Immunome, Inc. | -8.9 Million USD | 3095.88% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 14218.677% |
| Verona Pharma plc | -679.62 Thousand USD | 39363.328% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 152581.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 11288.386% |
| CervoMed Inc. | -1.29 Million USD | 20727.507% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 11186.124% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 5685.995% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -10698.988% |
| Moolec Science SA | -143.3 Thousand USD | 186306.343% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 65497.887% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 10088.404% |
| AnaptysBio, Inc. | 14.78 Million USD | -1705.311% |
| Design Therapeutics, Inc. | -537 Thousand USD | 49791.434% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 62592.506% |
| NeurAxis, Inc. | 2.15 Million USD | -12272.722% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -12334.436% |
| Lumos Pharma, Inc. | 2 Million USD | -13195.615% |
| Achilles Therapeutics plc | -4.73 Million USD | 5739.99% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 152581.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 252612.893% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -742.873% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -30852.494% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 25956.88% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 685.85% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -620465.116% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 32562.652% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 2028090.576% |
| Palisade Bio, Inc. | 246 Thousand USD | -108372.764% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 808715.152% |
| Beam Therapeutics Inc. | -59.67 Million USD | 547.183% |
| Neurogene Inc. | -3.26 Million USD | 8280.349% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -91.512% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 7327.6% |
| Sesen Bio, Inc. | 40 Million USD | -567.108% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 89946.128% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 6726.286% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2889.494% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1795.192% |
| Athira Pharma, Inc. | -969 Thousand USD | 27637.977% |
| Vaccinex, Inc. | -16 Million USD | 1767.352% |
| HCW Biologics Inc. | -574.82 Thousand USD | 46521.687% |
| XOMA Corporation | 3.86 Million USD | -6811.241% |
| Nektar Therapeutics | 53.47 Million USD | -398.977% |
| Arvinas, Inc. | 71.8 Million USD | -271.648% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 419.722% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 525.078% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 82970.497% |
| Rezolute, Inc. | -36 Thousand USD | 741330.556% |
| Clene Inc. | 533 Thousand USD | -49964.353% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 20782265.109% |
| BeyondSpring Inc. | 1.75 Million USD | -15139.463% |
| Synlogic, Inc. | -1.92 Million USD | 13969.179% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 721297.297% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 4314.198% |
| Peak Bio, Inc. | 367.76 Thousand USD | -72457.23% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1507.177% |
| Krystal Biotech, Inc. | 47.6 Million USD | -460.536% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -89.128% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -5210.308% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 10405.926% |
| MannKind Corporation | 136.19 Million USD | -95.933% |
| Ikena Oncology, Inc. | -50.49 Million USD | 628.486% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -145.229% |
| Gossamer Bio, Inc. | -4.38 Million USD | 6185.359% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 105990.079% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 5336960.0% |
| Legend Biotech Corporation | 140.92 Million USD | -89.346% |
| Mural Oncology plc | -2.56 Million USD | 10495.131% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 48528.857% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 266943.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1185.743% |
| REGENXBIO Inc. | 53.02 Million USD | -403.202% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 5081.246% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 138809.812% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 15506.64% |
| Vaxart, Inc. | -60.76 Million USD | 539.154% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 101646.16% |
| Cellectis S.A. | 18 Thousand USD | -1482361.111% |
| Longeveron Inc. | 221 Thousand USD | -120643.439% |
| Repare Therapeutics Inc. | -80.07 Million USD | 433.262% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 75.586% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 20721.561% |
| Revolution Medicines, Inc. | -399.66 Million USD | 166.767% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 762508.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -544477.551% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 96.9% |
| Denali Therapeutics Inc. | -93.34 Million USD | 385.867% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1065384.043% |
| Veru Inc. | 7.56 Million USD | -3426.904% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 176817.219% |
| Cingulate Inc. | -582.91 Thousand USD | 45877.108% |
| Passage Bio, Inc. | -3.72 Million USD | 7271.271% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 2215667.918% |
| Exicure, Inc. | -1.42 Million USD | 18852.143% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 69771.802% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -9772.105% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 52149.154% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -291.69% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 178462.643% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 550.703% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -68146.292% |
| OmniAb, Inc. | 14.66 Million USD | -1719.343% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1234.682% |
| Lipocine Inc. | -2.85 Million USD | 9460.226% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 14578.73% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 4777.353% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 17815.236% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -254.298% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 410627.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -216.555% |
| Ocugen, Inc. | -33.53 Million USD | 895.667% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 8539.058% |
| Q32 Bio Inc. | 578 Thousand USD | -46066.609% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 100795.472% |
| Alumis Inc. Common Stock | -1.28 Million USD | 20882.165% |
| Equillium, Inc. | 35.95 Million USD | -642.096% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 15732.279% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -53196.224% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 6454937.929% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 103128.185% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -63026.431% |
| Dominari Holdings Inc. | 2.03 Million USD | -12986.954% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 145541.514% |
| vTv Therapeutics Inc. | -13.59 Million USD | 2062.803% |
| Bio-Techne Corporation | 773.07 Million USD | 65.483% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1440.753% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 42.09% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 22926.604% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1212.773% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -2181.294% |
| Nkarta, Inc. | -5.86 Million USD | 4646.652% |
| BioCardia, Inc. | -7.24 Million USD | 3781.101% |
| Iterum Therapeutics plc | -1.75 Million USD | 15348.171% |